GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NIBEC Co Ltd (XKRX:138610) » Definitions » Cyclically Adjusted Price-to-FCF

NIBEC Co (XKRX:138610) Cyclically Adjusted Price-to-FCF : (As of Jun. 04, 2025)


View and export this data going back to 2011. Start your Free Trial

What is NIBEC Co Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


NIBEC Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for NIBEC Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIBEC Co Cyclically Adjusted Price-to-FCF Chart

NIBEC Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NIBEC Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NIBEC Co's Cyclically Adjusted Price-to-FCF

For the Biotechnology subindustry, NIBEC Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NIBEC Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NIBEC Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NIBEC Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

NIBEC Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

NIBEC Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, NIBEC Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-349.396/122.5900*122.5900
=-349.396

Current CPI (Mar. 2025) = 122.5900.

NIBEC Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -155.044 100.051 -189.972
201509 -342.582 100.111 -419.506
201512 -164.775 100.220 -201.553
201603 -280.729 100.561 -342.226
201606 -30.544 100.791 -37.150
201609 -383.731 101.461 -463.641
201612 18.934 101.561 22.854
201703 121.720 102.851 145.081
201706 -171.621 102.611 -205.036
201709 -137.794 103.491 -163.224
201712 -250.932 102.991 -298.684
201803 -124.646 104.101 -146.784
201806 -131.955 104.130 -155.347
201809 -124.747 105.651 -144.748
201812 -213.745 104.351 -251.105
201903 -64.391 104.491 -75.544
201906 -168.115 104.881 -196.501
201909 -110.681 105.200 -128.977
201912 -198.446 105.121 -231.423
202003 -47.433 105.354 -55.193
202006 -172.730 105.112 -201.452
202009 -148.685 106.198 -171.636
202012 -127.220 105.765 -147.457
202103 -113.221 107.357 -129.286
202106 -115.532 107.579 -131.653
202109 20.428 108.759 23.026
202112 -33.484 109.676 -37.426
202203 44.360 111.848 48.620
202206 506.797 114.072 544.639
202209 -143.827 114.715 -153.700
202212 -42.154 115.179 -44.866
202303 -29.087 116.507 -30.606
202306 -318.027 117.182 -332.704
202309 -437.396 118.964 -450.729
202312 -182.034 118.837 -187.783
202403 -177.598 120.123 -181.245
202406 6.581 120.007 6.723
202409 -152.277 120.861 -154.455
202412 -44.409 121.135 -44.942
202503 -349.396 122.590 -349.396

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NIBEC Co  (XKRX:138610) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


NIBEC Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of NIBEC Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NIBEC Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
Iwol Electronics & Civil Engineering & Construction 1 Complex, Jincheon-hun, KOR
NIBEC Co Ltd is a South Korea based biotechnology company. It manufactures and markets medicines for mouth, teeth health and tissue recovery. The company's main products are teeth whitening products, materials related to a dental implant, Regenomer, Equimatrix-collagen, OssGen-X 15. It is also involved in cosmetic production and sales.

NIBEC Co Headlines

No Headlines